The initial May reading represents the highest level of the index since July 2007, lifting stocks yet again on Friday to test new all-time highs.

Rallies in a bull market can reveal a lot about an imminent correction -Watch closely for fatigue

While benefits from deep-seated reforms will play out over a number of years, two sectors poised in coming months to cash in on a commitment to reform are healthcare stocks and industrials.

With the surprising market shift happening globally and across industries, business angels assisting startups and fueling innovation comes just at the right time.

Biogen Idec, Pfizer, Bristol-Myers, and Celgene are among companies awaiting US approval decisions on potential blockbuster treatments.

As the broader market begins to experience a pullback, investors may need to anticipate a similar move in the master limited partnerships segment as well.

For consumers, the all-important credit score is now the ultimate number that determines a borrowers' worthiness to lenders. Why and how did this happen, and who's profiting from it?

With interest rates at historically low levels for the foreseeable future, the question is what can companies do to lock in these low rates, and more importantly, are there any risks?

The market may attempt a technical rebound after failing to break down with momentum yesterday. Economic data releases will highlight the morning, with China and Europe on tap.